BOMYNTRA (Denosumab)

**Product type:** Human Prescription Drug

**Active ingredient:** DENOSUMAB

**Strength:** 70 mg/mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Fresenius Kabi USA, LLC

**Marketing category:** BLA (BLA761398)

**Pharmacologic class:** RANK Ligand Blocking Activity [MoA], RANK Ligand Inhibitor [EPC]